John Gordon Freund's Net Worth
Estimate Recalculated Sep 15, 2025 08:39PM EST
Who is John Gordon Freund
John Gordon Freund has an estimated net worth of $6.01 Million. This is based on reported shares across multiple companies, which include Dicerna Pharmaceuticals Inc, MAKO Surgical Corp., MAP Pharmaceuticals, Inc., TETRAPHASE PHARMACEUTICALS INC, Targanta Therapeutics Corp., Sirtris Pharmaceuticals, Inc., SI-BONE, Inc., COLLEGIUM PHARMACEUTICAL, INC, SUTRO BIOPHARMA, INC., CONCERT PHARMACEUTICALS, INC., PROTEON THERAPEUTICS INC, ACELRX PHARMACEUTICALS INC, XENOPORT INC, and HANSEN MEDICAL INC.
SEC CIK
John Gordon Freund's CIK is 0001296771
Past Insider Trading and Trends
2015 was John Gordon Freund's most active year for acquiring shares with 7 total transactions. John Gordon Freund's most active month to acquire stocks was the month of April. 2016 was John Gordon Freund's most active year for disposing of shares, totalling 8 transactions. John Gordon Freund's most active month to dispose stocks was the month of June. 2019 saw John Gordon Freund paying a total of $699,999.70 for 761,560 shares, this is the most they've acquired in one year. In 2007 John Gordon Freund cashed out on 2,418,669 shares for a total of $35,075,537.83, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
